Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune and inflammatory biomarkers in advanced prostate cancer with cardiovascular disease treated with degarelix vs GnRH agonist
2016-004120-39Phase 2Completed
- Sponsor
- Region Skåne
- Start
- Jan 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of degarelix and leuprolide in prostate cancer (PCa) (2 arms), sponsored by Region Skåne. Started Jan 2017; status: completed.
02
Drugs
degarelixleuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2016-004120-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004120-39.